Published in Drug Saf on October 01, 1994
Gender differences in metformin effect on aging, life span and spontaneous tumorigenesis in 129/Sv mice. Aging (Albany NY) (2010) 1.22
Insulin resistance. BMJ (1996) 1.00
The prevalence of potential alcohol-drug interactions in older adults. Scand J Prim Health Care (2013) 0.90
Glibenclamide in patients with poorly controlled type 2 diabetes: a 12-week, prospective, single-center, open-label, dose-escalation study. Clin Pharmacol (2014) 0.89
Characteristics and time course of severe glimepiride- versus glibenclamide-induced hypoglycaemia. Eur J Clin Pharmacol (2003) 0.82
Effect of the urotensin-II receptor antagonist palosuran on secretion of and sensitivity to insulin in patients with Type 2 diabetes mellitus. Br J Clin Pharmacol (2009) 0.82
Prediction and validation of enzyme and transporter off-targets for metformin. J Pharmacokinet Pharmacodyn (2015) 0.80
Sex differences in aging, life span and spontaneous tumorigenesis in 129/Sv mice neonatally exposed to metformin. Cell Cycle (2015) 0.79
Cytoprotective Effects of Hydrophilic and Lipophilic Extracts of Pistacia vera against Oxidative Versus Carbonyl Stress in Rat Hepatocytes. Iran J Pharm Res (2014) 0.77
Unexploited Antineoplastic Effects of Commercially Available Anti-Diabetic Drugs. Pharmaceuticals (Basel) (2016) 0.75
Metformin allergy. Indian J Pharmacol (2011) 0.75
Comparative molecular field analysis of benzothiazepine derivatives: mitochondrial sodium calcium exchange inhibitors as antidiabetic agents. Indian J Pharm Sci (2010) 0.75
Localization of the gene for familial adenomatous polyposis on chromosome 5. Nature (1987) 10.21
Newly licensed drugs. BMJ (1996) 6.68
Medical errors. Medical schools can teach safe drug prescribing and administration. BMJ (2001) 3.53
Joining the DoTS: new approach to classifying adverse drug reactions. BMJ (2003) 3.47
Systematic review and meta-analysis of ethnic differences in risks of adverse reactions to drugs used in cardiovascular medicine. BMJ (2006) 3.02
Accumulation of metformin by tissues of the normal and diabetic mouse. Xenobiotica (1994) 2.94
Traditional plant treatments for diabetes. Studies in normal and streptozotocin diabetic mice. Diabetologia (1990) 2.75
Is there a cure for drug errors? BMJ (1995) 2.55
Financial ties as part of informed consent to postmarketing research. Attitudes of American doctors and patients. BMJ (1995) 2.36
Peritonitis in continuous ambulatory peritoneal dialysis. Laboratory and clinical studies. Lancet (1982) 2.30
Misleading drug packaging. BMJ (1995) 2.12
Thiazolidinediones for type 2 diabetes. New agents reduce insulin resistance but need long term clinical trials. BMJ (2000) 2.08
The antihyperglycaemic effect of metformin: therapeutic and cellular mechanisms. Drugs (1999) 1.94
Leptin rapidly suppresses insulin release from insulinoma cells, rat and human islets and, in vivo, in mice. J Clin Invest (1997) 1.89
'The strategy of desire' and rational prescribing. Br J Clin Pharmacol (1994) 1.84
Minocycline for acne. BMJ (1996) 1.61
Subcellular distribution of metformin in rat liver. J Pharm Pharmacol (1991) 1.50
Effects of intradermal bradykinin after inhibition of angiotensin converting enzyme. Br Med J (Clin Res Ed) (1987) 1.46
Why are thiazide diuretics declining in popularity? J Hum Hypertens (2001) 1.44
Lead poisoning from Asian traditional remedies in the West Midlands--report of a series of five cases. Hum Exp Toxicol (1995) 1.42
Alternative venlafaxine kinetics in overdose. J Clin Pharm Ther (2002) 1.40
Serum lipids and apolipoproteins in liver transplant recipients: a comparative study of cyclosporin A and FK 506. J Lab Clin Med (1994) 1.39
The structure of legumin, a storage protein of broad bean (Vicia faba) seed. Eur J Biochem (1970) 1.37
Improving prescribing using a rule based prescribing system. Qual Saf Health Care (2004) 1.29
A comparative study of two serotypes of epidermolytic toxin from Staphylococcus aureus. Biochim Biophys Acta (1980) 1.28
Where errors occur in the preparation and administration of intravenous medicines: a systematic review and Bayesian analysis. Qual Saf Health Care (2010) 1.27
Metformin and the intestine. Diabetologia (2008) 1.25
Abnormal plasma glucose and insulin responses in heterozygous lean (ob/+) mice. Diabetologia (1981) 1.24
Adverse drug reaction teaching in UK undergraduate medical and pharmacy programmes. J Clin Pharm Ther (2004) 1.23
Increased neuropeptide-Y messenger ribonucleic acid (mRNA) and decreased neurotensin mRNA in the hypothalamus of the obese (ob/ob) mouse. Endocrinology (1993) 1.22
Sites of metformin-stimulated glucose metabolism. Biochem Pharmacol (1990) 1.20
Hazards, risks and reality. Br J Clin Pharmacol (1992) 1.20
Inhibition of hepatic gluconeogenesis by metformin. Synergism with insulin. Biochem Pharmacol (1988) 1.19
Late-onset optic pathway tumors in children with neurofibromatosis 1. Neurology (2004) 1.17
Insulin-like effect of pinitol. Br J Pharmacol (2000) 1.17
Improvement in glucose tolerance due to Momordica charantia (karela). Br Med J (Clin Res Ed) (1981) 1.16
A risk-benefit assessment of metformin in type 2 diabetes mellitus. Drug Saf (1999) 1.15
Cervical cord compression from plexiform neurofibromas in neurofibromatosis 1. J Neurol Neurosurg Psychiatry (2007) 1.14
Adverse drug reactions: who is to know? BMJ (1993) 1.13
Thyroid hormones, gonadal and adrenocortical steroids and the function of the islets of Langerhans. Endocr Rev (1984) 1.12
Role of ovarian hormones in the long-term control of glucose homeostasis. Effects of insulin secretion. Diabetologia (1980) 1.11
Adverse drug reactions in patients admitted to hospital identified by discharge ICD-10 codes and by spontaneous reports. Br J Clin Pharmacol (2001) 1.09
Hopelessness and violence among inner-city youths. Matern Child Health J (2001) 1.07
Identification of novel deletion breakpoints bordered by segmental duplications in the NF1 locus using high resolution array-CGH. J Med Genet (2005) 1.06
Tailoring treatment to the individual in type 2 diabetes practical guidance from the Global Partnership for Effective Diabetes Management. Int J Clin Pract (2010) 1.06
The isolation and characterisation of gas-cylinder membranes and alpha-granules from Anabaena flos-aquae D 124. Arch Mikrobiol (1969) 1.06
Hypoglycaemic effect of Momordica charantia extracts. Planta Med (1990) 1.05
Prospective study of post-transfusion hepatitis after cardiac surgery in a British centre. Br Med J (Clin Res Ed) (1983) 1.05
Traditional dietary adjuncts for the treatment of diabetes mellitus. Proc Nutr Soc (1991) 1.04
The amino acid sequence of plastocyanin from Solanum tuberosum L. (potato). Biochem J (1974) 1.04
Prevention of dexamethasone-induced insulin resistance by metformin. Biochem Pharmacol (1998) 1.02
Effect of metformin on glucose metabolism in mouse soleus muscle. Diabete Metab (1986) 1.02
The relationship between the pharmacokinetics and pharmacodynamic effects of oral hypoglycaemic drugs. Clin Pharmacokinet (1987) 1.01
The role of the serine protease active site in the mode of action of epidermolytic toxin of Staphylococcus aureus. FEMS Microbiol Lett (1991) 1.00
The influence of big pharma. BMJ (2005) 1.00
Glucose tolerance and plasma insulin of the rat in relation to the oestrous cycle and sex hormones. Horm Metab Res (1972) 1.00
The safety of spironolactone treatment in patients with heart failure. J Clin Pharm Ther (2003) 0.99
The impact of PET scanning on management of paediatric oncology patients. Eur J Nucl Med Mol Imaging (2004) 0.99
Bromocriptine: old drug, new formulation and new indication. Diabetes Obes Metab (2010) 0.98
Alcohol intake: measure for measure. BMJ (2001) 0.97
Recombinant epidermolytic (exfoliative) toxin A of Staphylococcus aureus is not a superantigen. Med Microbiol Immunol (1992) 0.97
The UK Prospective Diabetes Study. Lancet (1998) 0.97
Testing the practical aspects of therapeutics by objective structured clinical examination. J Clin Pharm Ther (2004) 0.97
Role of ovarian hormones in the long-term control of glucose homeostasis. Interaction with insulin, glucagon and epinephrine. Horm Res (1980) 0.96
Poisoning with anti-hypertensive drugs: calcium antagonists. J Hum Hypertens (1995) 0.96
Epidermolytic toxin from Staphylococcus aureus binds to filaggrins. FEBS Lett (1986) 0.95
Epidermolytic toxin binds to components in the epidermis of a resistant species. Eur J Cell Biol (1989) 0.95
Glycaemic effects of traditional European plant treatments for diabetes. Studies in normal and streptozotocin diabetic mice. Diabetes Res (1989) 0.95
Specific binding of the C-peptide of proinsulin to cultured B-cells from a transplantable rat islet cell tumor. Biosci Rep (1986) 0.93
Systemic toxicity related to metal hip prostheses. Clin Toxicol (Phila) (2014) 0.92
Immunoreactive gastric inhibitory polypeptide and K cell hyperplasia in obese hyperglycaemic (ob/ob) mice fed high fat and high carbohydrate cafeteria diets. Acta Endocrinol (Copenh) (1986) 0.92
Anabolic steroids: the power and the glory? BMJ (1988) 0.91
Monitoring for adverse drug reactions. Br J Clin Pharmacol (2006) 0.91
The rise and fall of troglitazone. Diabet Med (2000) 0.91
Abnormalities of GIP in spontaneous syndromes of obesity and diabetes in mice. Diabetes (1983) 0.91
Evaluation of traditional plant treatments for diabetes: studies in streptozotocin diabetic mice. Acta Diabetol Lat (1989) 0.90
The electrophoretic mobility of peptides on paper at pH 1.9. Biochem J (1973) 0.90
The subunit structure of jack-bean urease. Biochem J (1969) 0.90
Atropine treatment for baclofen overdose. Postgrad Med J (1981) 0.90
Valproic acid and fetal abnormality. Br Med J (Clin Res Ed) (1983) 0.90
Screening for symptomatic optic pathway glioma in children with neurofibromatosis type 1. Eye (Lond) (2011) 0.89
Insulin and glucagon during pentobarbitone anaesthesia. Diabete Metab (1980) 0.89
Differential effects of metformin on bile salt absorption from the jejunum and ileum. Diabetes Obes Metab (2003) 0.89
Role of ovarian hormones in the long-term control of glucose homeostasis, glycogen formation and gluconeogenesis. Ann Nutr Metab (1981) 0.89
RFLP for the human erb-A1 gene. Nucleic Acids Res (1987) 0.89
The lacing defence: double blind study of thresholds for detecting addition of ethanol to drinks. BMJ (2000) 0.89
Cloning and characterization of the gene for a methanol-utilising alcohol dehydrogenase from Bacillus stearothermophilus. Gene (1988) 0.88
Development of glucose intolerance and impaired plasma insulin response to glucose in obese hyperglycaemic (ob/ob) mice. Horm Metab Res (1981) 0.88
Influence of genetic background and age on the expression of the obese hyperglycaemic syndrome in Aston ob/ob mice. Int J Obes (1982) 0.88
Hormonal control of glucose homeostasis during development and ageing in mice. Metabolism (1982) 0.88
Effect of ovarian hormones on glucose metabolism in mouse soleus muscle. Endocrinology (1985) 0.87
Stimulation of gastric inhibitory polypeptide release in ob/ob mice by oral administration of sugars and their analogues. J Nutr (1989) 0.87
Reconsideration of inhibitory effect of metformin on intestinal glucose absorption. J Pharm Pharmacol (1991) 0.86
Poisoning with anti-hypertensive drugs: angiotensin converting enzyme inhibitors. J Hum Hypertens (1995) 0.86
Recent advances in antidiabetic drug therapies targeting the enteroinsular axis. Curr Drug Metab (2009) 0.86
Dark-adapted sensitivity, rhodopsin content, and background adaptation in pcd/pcd mice. Invest Ophthalmol Vis Sci (1982) 0.86
The binding of epidermolytic toxin from Staphylococcus aureus to mouse epidermal tissue. Histochem J (1987) 0.86
Leptin prevents the fall in plasma osteocalcin during starvation in male mice. Biochem Biophys Res Commun (2002) 0.86
An analysis and comparison of commonly available United Kingdom prescribing resources. J Clin Pharm Ther (2010) 0.86